Alert FDA Updates Axi-Cel Safety Label for Large B-Cell Lymphoma The FDA has removed R/R PCNSL from a Limitations of Use section on the CAR-T product’s label based on positive findings from phase 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results